Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

111

Actual shortage: 2 (2%)
Anticipated shortage: 1 (1%)
Avoided shortage: 5 (5%)
Resolved: 103 (93%)

Discontinuation Reports

9

To be discontinued: 0 (0%)
Discontinued: 8 (89%)
Reversed: 1 (11%)

Late reports

3 (3%)

Overdue reports

2 (67%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACUVAIL 0.45% SOLUTION Avoided shortage 2019-10-24 2019-11-07 97097
ACUVAIL 0.45% SOLUTION Resolved 2019-12-07 2019-12-21 100509
ACUVAIL 0.45% SOLUTION Resolved 2021-01-19 2021-05-06 131991
ACUVAIL 0.45% SOLUTION Resolved 2022-01-19 2022-03-01 153071
ACUVAIL 0.45% SOLUTION Resolved 2022-10-26 2023-04-29 172625
ACULAR LS 0.4% SOLUTION Resolved 2023-06-06 2023-07-06 193833
ACULAR 0.5% SOLUTION Resolved 2018-11-06 2019-02-21 66328
ACULAR 0.5% SOLUTION Resolved 2019-02-15 2019-03-15 75873
ACTONEL DR 35MG TABLET (DELAYED-RELEASE) Avoided shortage 2019-10-03 2019-10-03 95288
ACTONEL DR 35MG TABLET (DELAYED-RELEASE) Resolved 2020-06-12 2020-06-19 117615
ACTONEL 35MG TABLET Resolved 2019-09-16 2019-10-12 93950

Showing 101 to 111 of 111

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885

Showing 1 to 9 of 9